Spiroxatrine


Spiroxatrine

chembox new
ImageFile=Spiroxatrine.svg
ImageSize=
IUPACName=8-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro [4.5] decan-4-one
OtherNames=
Section1=Chembox Identifiers
CASNo=
PubChem=5268
SMILES=C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CC4COC5=CC=CC=C5O4
MeSHName=Spiroxatrine

Section2=Chembox Properties
C=22|H=25|N=3|O=3
Appearance=
Density=
MeltingPt=
BoilingPt=
Solubility=

Section3=Chembox Hazards
MainHazards=
FlashPt=
Autoignition=

Spiroxatrine is a ligand at the 5-HT1A receptor. It is an analogue of spiperone, and also has dopamine antagonist and adrenergic antagonist effects.


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Dimethyltryptamine — Systematic (IUPAC) name 2 (1H indol 3 yl) N …   Wikipedia

  • Monoamine oxidase inhibitor — MAOI redirects here. For the Easter Island statues, see Moai. Monoamine oxidase Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant drugs prescribed for the treatment of depression. They are particularly effective in treating… …   Wikipedia

  • Phenothiazine — Phenothiazine …   Wikipedia

  • Clozapine — Not to be confused with clonazepam or Klonopin. Clozapine Systematic (IUPAC) name …   Wikipedia

  • Chlorpromazine — Systematic (IUPAC) name …   Wikipedia

  • Monoamine neurotransmitter — Norepinephrine is a monoamine neurotransmitter …   Wikipedia

  • Phenelzine — Systematic (IUPAC) name (±) 2 phenylethylhydrazine …   Wikipedia

  • Aripiprazole — Systematic (IUPAC) name 7 {4 [4 (2,3 dichlorophenyl)piperazin 1 yl]butoxy} 3,4 dihydroquinolin 2(1H) one Clinical data Trade names …   Wikipedia

  • Loxapine — Systematic (IUPAC) name 2 Chloro 11 (4 methylpiperazin 1 yl)dibenzo[b,f][1,4]oxazepine Clinical data AHFS/Drugs.com …   Wikipedia

  • Tranylcypromine — Systematic (IUPAC) name (±) trans 2 phenylcyclopropan 1 amine or (1R*,2S*) 2 phenylcyclopropan 1 amine …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.